Carine de Beaufort

Summary

Affiliation: Centre Hospitalier de Luxembourg
Country: Luxembourg

Publications

  1. ncbi request reprint European Union diabetes indicators: fact or fiction?
    C E de Beaufort
    Clinique Pediatrique Luxemburg, GD de Luxemburg
    Eur J Public Health 13:51-4. 2003
  2. ncbi request reprint Acute pancreatitis after growth hormone treatment: disease or treatment linked?
    Carine de Beaufort
    DECCP, Clinique Pédiatrique de Luxembourg, 4, Rue Barble, 1210 Luxembourg, Grand Duchy of Luxembourg
    Eur J Pediatr 165:652-3. 2006
  3. doi request reprint Metabolic outcomes in young children with type 1 diabetes differ between treatment centers: the Hvidoere Study in Young Children 2009
    Carine E de Beaufort
    Pediatric Clinic, Centre Hospitalier de Luxembourg, Luxembourg, GD de Luxembourg
    Pediatr Diabetes 14:422-8. 2013
  4. doi request reprint Harmonize care to optimize outcome in children and adolescents with diabetes mellitus: treatment recommendations in Europe
    Carine de Beaufort
    DECCP, CHL de Luxembourg, 4 rue E Barblé, Luxembourg
    Pediatr Diabetes 13:15-9. 2012
  5. pmc Disease progression and search for monogenic diabetes among children with new onset type 1 diabetes negative for ICA, GAD- and IA-2 Antibodies
    Sven Pörksen
    Department of Pediatrics, Glostrup Hospital and University of Copenhagen, Copenhagen, Denmark
    BMC Endocr Disord 10:16. 2010
  6. ncbi request reprint Continuing stability of center differences in pediatric diabetes care: do advances in diabetes treatment improve outcome? The Hvidoere Study Group on Childhood Diabetes
    Carine E de Beaufort
    DECCP, Clinique Pédiatrique Centre Hospitalier, Luxembourg
    Diabetes Care 30:2245-50. 2007
  7. ncbi request reprint Co-localisation of the Kir6.2/SUR1 channel complex with glucagon-like peptide-1 and glucose-dependent insulinotrophic polypeptide expression in human ileal cells and implications for glycaemic control in new onset type 1 diabetes
    Lotte B Nielsen
    Department of Paediatrics, Glostrup University Hospital, Ndr Ringvej 57, DK 2600 Glostrup, Denmark
    Eur J Endocrinol 156:663-71. 2007
  8. ncbi request reprint A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countries
    Thomas Danne
    Kinderkrankenhaus auf der Bult, Hannover, Germany
    Pediatr Diabetes 6:193-8. 2005
  9. doi request reprint Relation of circulating concentrations of chemokine receptor CCR5 ligands to C-peptide, proinsulin and HbA1c and disease progression in type 1 diabetes
    C Pfleger
    Institute for Clinical Diabetes Research at German Diabetes Centre, Leibniz Institute at Heinrich Heine University Duesseldorf, Auf m Hennekamp 65, 40225 Duesseldorf, Germany
    Clin Immunol 128:57-65. 2008

Collaborators

Detail Information

Publications9

  1. ncbi request reprint European Union diabetes indicators: fact or fiction?
    C E de Beaufort
    Clinique Pediatrique Luxemburg, GD de Luxemburg
    Eur J Public Health 13:51-4. 2003
    ..Further harmonisation as well as continuous evaluation of data sources will be necessary to provide reliable tools to monitor diabetes mellitus and its outcome on a routine basis...
  2. ncbi request reprint Acute pancreatitis after growth hormone treatment: disease or treatment linked?
    Carine de Beaufort
    DECCP, Clinique Pédiatrique de Luxembourg, 4, Rue Barble, 1210 Luxembourg, Grand Duchy of Luxembourg
    Eur J Pediatr 165:652-3. 2006
  3. doi request reprint Metabolic outcomes in young children with type 1 diabetes differ between treatment centers: the Hvidoere Study in Young Children 2009
    Carine E de Beaufort
    Pediatric Clinic, Centre Hospitalier de Luxembourg, Luxembourg, GD de Luxembourg
    Pediatr Diabetes 14:422-8. 2013
    ..To investigate whether center differences in glycemic control are present in prepubertal children <11 yr with type 1 diabetes mellitus...
  4. doi request reprint Harmonize care to optimize outcome in children and adolescents with diabetes mellitus: treatment recommendations in Europe
    Carine de Beaufort
    DECCP, CHL de Luxembourg, 4 rue E Barblé, Luxembourg
    Pediatr Diabetes 13:15-9. 2012
    ..Identify and evaluate current treatment recommendations in Europe for the care of children with diabetes in view of the European Union (EU) recommendations for Reference Centers...
  5. pmc Disease progression and search for monogenic diabetes among children with new onset type 1 diabetes negative for ICA, GAD- and IA-2 Antibodies
    Sven Pörksen
    Department of Pediatrics, Glostrup Hospital and University of Copenhagen, Copenhagen, Denmark
    BMC Endocr Disord 10:16. 2010
    ..Furthermore the study aimed at determining whether mutations in KCNJ11, ABCC8, HNF1A, HNF4A or INS are common in AAB negative diabetes...
  6. ncbi request reprint Continuing stability of center differences in pediatric diabetes care: do advances in diabetes treatment improve outcome? The Hvidoere Study Group on Childhood Diabetes
    Carine E de Beaufort
    DECCP, Clinique Pédiatrique Centre Hospitalier, Luxembourg
    Diabetes Care 30:2245-50. 2007
    ....
  7. ncbi request reprint Co-localisation of the Kir6.2/SUR1 channel complex with glucagon-like peptide-1 and glucose-dependent insulinotrophic polypeptide expression in human ileal cells and implications for glycaemic control in new onset type 1 diabetes
    Lotte B Nielsen
    Department of Paediatrics, Glostrup University Hospital, Ndr Ringvej 57, DK 2600 Glostrup, Denmark
    Eur J Endocrinol 156:663-71. 2007
    ..2 subunit, Glu23Lys, exerts a functional impact on glucose-sensing tissues in vivo that may affect the overall glycaemic control in children with new-onset type 1 diabetes...
  8. ncbi request reprint A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countries
    Thomas Danne
    Kinderkrankenhaus auf der Bult, Hannover, Germany
    Pediatr Diabetes 6:193-8. 2005
    ....
  9. doi request reprint Relation of circulating concentrations of chemokine receptor CCR5 ligands to C-peptide, proinsulin and HbA1c and disease progression in type 1 diabetes
    C Pfleger
    Institute for Clinical Diabetes Research at German Diabetes Centre, Leibniz Institute at Heinrich Heine University Duesseldorf, Auf m Hennekamp 65, 40225 Duesseldorf, Germany
    Clin Immunol 128:57-65. 2008
    ..Blockage of chemokines or antagonism of CCR5 by therapeutic agents such as maraviroc may provide a new therapeutic target to ameliorate disease progression in type 1 diabetes...